Advanced

Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.

Piitulainen, Eeva LU ; Bernspång, Elisabeth LU ; Björkman, Sven and Berntorp, Erik LU (2003) In European Journal of Clinical Pharmacology 59(2). p.151-156
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Journal of Clinical Pharmacology
volume
59
issue
2
pages
151 - 156
publisher
Springer
external identifiers
  • wos:000184157900011
  • pmid:12728289
ISSN
1432-1041
DOI
10.1007/s00228-003-0589-z
language
English
LU publication?
yes
id
a7e6dbdc-b902-4f9c-85c1-840666e1a9e6 (old id 114225)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12728289&dopt=Abstract
date added to LUP
2007-07-30 10:27:49
date last changed
2016-04-16 05:09:50
@article{a7e6dbdc-b902-4f9c-85c1-840666e1a9e6,
  author       = {Piitulainen, Eeva and Bernspång, Elisabeth and Björkman, Sven and Berntorp, Erik},
  issn         = {1432-1041},
  language     = {eng},
  number       = {2},
  pages        = {151--156},
  publisher    = {Springer},
  series       = {European Journal of Clinical Pharmacology},
  title        = {Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.},
  url          = {http://dx.doi.org/10.1007/s00228-003-0589-z},
  volume       = {59},
  year         = {2003},
}